The present disclosure relates generally to toll like receptor modulator compounds, such as diamino pyrido[3,2 D]pyrimidine compounds and pharmaceutical compositions which, among other things, modulate toll-like receptors (e.g. TLR-8), and methods of making and using them.
Alkane functionalization on a preparative scale by mercury-photosensitized cross-dehydrodimerization
作者:Stephen H. Brown、Robert H. Crabtree
DOI:10.1021/ja00190a032
日期:1989.4
5-trioxacyclohexane < ethanol < isobutane < THF < Etsub3}SiH. The observed selectivities generally parallel those for homodimerization, reported in the preceding paper, but certain differences are noted, and reasons for the differences are proposed. The bond-dissociation energymore » of Etsub3}SiH is estimated from the reactivity data to be 90 kcal/mol. Eleven new carbinols are synthesized. 39 refs., 6 tabs
[DE] VERFAHREN ZUR HERSTELLUNG VON OLEFINEN MIT 8 BIS 12 KOHLENSTOFFATOMEN<br/>[EN] METHOD FOR THE PRODUCTION OF OLEFINS COMPRISING 8 TO 12 CARBON ATOMS<br/>[FR] PROCEDE POUR PRODUIRE DES OLEFINES AVEC 8 A 12 ATOMES DE CARBONE
申请人:OXENO OLEFINCHEMIE GMBH
公开号:WO2005080302A1
公开(公告)日:2005-09-01
Die vorliegende Erfindung betrifft die Herstellung von Olefinen oder Olefingemischen mit 8 bis 12 Kohlenstoffatomen durch eine vierstufige Synthese aus einem oder mehreren Olefin(en) mit 4 bis 6 Kohlenstoffatomen. Die vierstufige Synthese umfasst die Schritte Hydroformylierung zum Aldehyd, Hydrierung zum Alkohol, Wasserabspaltung zum 1-Olefin und Metathese. Die erhaltenen C8- bis C12-Olefine können z. B. zur Herstellung von Weichmacheralkoholen, insbesondere Isononanol eingesetzt werden.
This is the translation of the text into Chinese:
该发明涉及通过从含有4至6个碳原子的一个或多个烯烃进行的四步合成来制备具有8至12个碳原子的烯烃或烯烃混合物。这四步合成包括羰基化制备醛,加氢制备醇,脱水制备1-烯烃和醚交换反应。得到的C8至C12烯烃可用于生产软化剂醇,特别是异壬醇。
The present invention provides a compound having antiviral effects, particularly having growth inhibitory activity on influenza viruses, a preferred example of the compound being a substituted 3-hydroxy-4-pyridone derivative prodrug having cap-dependent endonuclease inhibitory activity.
Provided herein is technology relating to natural lipids containing non-β-oxidizable fatty acids and particularly, but not exclusively, to compositions and methods related to the production and use of natural lipids containing non-β-oxidizable fatty acids.